Top 21 Ardelyx investors
The most complete profiles first. Showing 21 of 21.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
David MottVerified
Venture Capital, Angel/Individual, Investor · United States
SeedPre-SeedEnterprise SoftwareBiotechnologyHealth and Hospital ServicesConsumer InternetPortfolio: Nightstar Therapeutics, Ardelyx, Cydan, Adaptimmune and 4 more
Verified email available
David ShuVerified
Venture Capital · France
Health CareWearablesE-commerceCybersecurityPortfolio: Tamara Mellon, Synaptive Medical, RDG GmbH & Co. KG, BlueJeans Network and 20 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
James Flynn
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more
Contact details available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Avi Kometz
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Caroline Stout
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Ardelyx investors are on Angel Roster?
Angel Roster lists 21 Ardelyx investors. 15 of them (71%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (11) and Hedge Funds (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Ardelyx investors invest in?
Among those that list a stage, the most common are Seed (8), Series B (4) and Pre-Seed (1).
Where are Ardelyx investors based?
Most are based in the United States (19), the United Kingdom (1) and France (1).
Which companies have Ardelyx investors backed?
The most-backed portfolio companies among them are Akari Therapeutics (15), Audentes Therapeutics (15), Generation Bio (15), AveXis (15) and REGENXBIO (15).
How do I contact Ardelyx investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.